X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4431) 4431
Newsletter (809) 809
Publication (519) 519
Newspaper Article (511) 511
Book Review (110) 110
Magazine Article (69) 69
Book Chapter (53) 53
Trade Publication Article (51) 51
Book / eBook (30) 30
Dissertation (19) 19
Conference Proceeding (13) 13
Web Resource (12) 12
Transcript (8) 8
Reference (7) 7
Data Set (5) 5
Report (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3267) 3267
human papillomavirus (2631) 2631
female (2534) 2534
index medicus (2361) 2361
vaccines (2145) 2145
papillomavirus infections (2022) 2022
cervical cancer (1847) 1847
cancer (1443) 1443
papillomavirus infections - prevention & control (1412) 1412
papillomavirus vaccines - therapeutic use (1368) 1368
vaccination (1229) 1229
research (1064) 1064
adult (1013) 1013
uterine cervical neoplasms - prevention & control (1011) 1011
health aspects (965) 965
immunology (950) 950
adolescent (939) 939
male (855) 855
oncology (840) 840
immunization (829) 829
medical research (749) 749
uterine cervical neoplasms - virology (715) 715
papillomaviruses (714) 714
animals (704) 704
medicine, research & experimental (698) 698
prevention (673) 673
infection (605) 605
care and treatment (597) 597
women (580) 580
hpv (571) 571
immunotherapy (570) 570
young adult (569) 569
medicine, experimental (558) 558
middle aged (553) 553
cervical-cancer (505) 505
papillomavirus infections - virology (505) 505
child (483) 483
risk factors (482) 482
infections (477) 477
infectious diseases (443) 443
papillomavirus infections - complications (425) 425
analysis (422) 422
mice (416) 416
proteins (416) 416
human-papillomavirus (413) 413
papillomavirus infections - epidemiology (412) 412
womens health (399) 399
vaccine (397) 397
medicine (392) 392
clinical trials (378) 378
papillomavirus vaccines - immunology (375) 375
studies (372) 372
papillomaviridae - immunology (371) 371
papillomavirus infections - immunology (371) 371
cancer vaccines (370) 370
tumors (367) 367
viruses (366) 366
article (359) 359
public health (359) 359
prevalence (340) 340
antigens (338) 338
young-women (337) 337
diagnosis (335) 335
research article (329) 329
papillomavirus vaccines - administration & dosage (328) 328
health knowledge, attitudes, practice (323) 323
united-states (309) 309
virus diseases (307) 307
public, environmental & occupational health (304) 304
particle vaccine (300) 300
human-papillomavirus type-16 (299) 299
allergy and immunology (294) 294
deoxyribonucleic acid--dna (282) 282
epidemiology (277) 277
virus-like particles (270) 270
aged (266) 266
uterine cervical neoplasms - epidemiology (265) 265
intraepithelial neoplasia (262) 262
papillomavirus vaccines (251) 251
cervical intraepithelial neoplasia (250) 250
cervix (250) 250
hpv vaccine (250) 250
genetic aspects (249) 249
virology (247) 247
papillomaviridae - genetics (246) 246
dna (245) 245
review (244) 244
cancer vaccines - therapeutic use (241) 241
risk (238) 238
immune system (237) 237
multidisciplinary sciences (236) 236
papillomavirus infections - therapy (236) 236
mice, inbred c57bl (235) 235
sexually transmitted diseases (234) 234
uterine cervical neoplasms - immunology (230) 230
usage (215) 215
dendritic cells (214) 214
biotechnology & applied microbiology (210) 210
science (210) 210
efficacy (209) 209
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5794) 5794
French (54) 54
German (48) 48
Spanish (22) 22
Chinese (12) 12
Bulgarian (8) 8
Japanese (8) 8
Polish (7) 7
Danish (4) 4
Russian (4) 4
Czech (3) 3
Portuguese (3) 3
Hungarian (2) 2
Italian (2) 2
Korean (2) 2
Arabic (1) 1
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Summary Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current... 
Internal Medicine | REGRESSION | MEDICINE, GENERAL & INTERNAL | ELECTROPORATION | METHYLATION | INTEGRATION | IMMUNOTHERAPY | E2 BINDING-SITES | NATURAL-HISTORY | CANCER | BURDEN | EXPRESSION | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 19, pp. 1838 - 1847
Journal Article
Biomacromolecules, ISSN 1525-7797, 08/2013, Volume 14, Issue 8, pp. 2798 - 2806
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2008, Volume 14, Issue 1, pp. 178 - 187
Journal Article
Immunologic Research, ISSN 0257-277X, 7/2010, Volume 47, Issue 1, pp. 86 - 112
It is now well established that most cervical cancers are causally associated with HPV infection. This realization has led to efforts to control HPV-associated... 
Allergology | Immunology | Medicine & Public Health | Therapeutic vaccine | HPV E6 | Internal Medicine | DNA vaccines | Medicine/Public Health, general | Cervical cancer | HPV | HPV E7 | CELL IMMUNE-RESPONSES | HUMAN-PAPILLOMAVIRUS TYPE-16 | CANCER-IMMUNOTHERAPY | IMMUNOLOGY | CERVICAL INTRAEPITHELIAL NEOPLASIA | CLASS-I PRESENTATION | E7 ONCOPROTEIN | PLASMID DNA | REGULATORY T-CELLS | VIRUS-LIKE PARTICLES | ANTITUMOR IMMUNITY | Vaccines, DNA - genetics | Antigens, Viral - metabolism | Papillomavirus Vaccines - genetics | Dendritic Cells - immunology | Humans | Vaccines, DNA - immunology | Antigens, Viral - genetics | Papillomaviridae - genetics | Papillomavirus Infections - therapy | Cancer Vaccines - genetics | Cancer Vaccines - therapeutic use | Papillomaviridae - immunology | Female | Oncogene Proteins, Viral - genetics | Uterine Cervical Neoplasms - therapy | Oncogene Proteins, Viral - metabolism | Papillomavirus Vaccines - therapeutic use | Uterine Cervical Neoplasms - prevention & control | Clinical Trials as Topic | Vaccines, DNA - therapeutic use | Antigens, Viral - immunology | Cancer Vaccines - immunology | Papillomavirus Infections - prevention & control | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus | Vaccines | Immunotherapy | Deoxyribonucleic acid--DNA | Infection | Antigen presentation | Dendritic cells | Antigen processing | Lymphocytes T | Malignancy
Journal Article
Journal Article
Human Gene Therapy, ISSN 1043-0342, 09/2018, Volume 29, Issue 9, pp. 971 - 996
Human papillomavirus (HPV) has long been recognized as the causative agent of cervical cancer. High-risk HPV types 16 and 18 alone are responsible for over 70%... 
Reviews | DNA vaccine | therapeutic vaccine | dendritic cells | HPV E6 | cervical cancer | HPV | HPV E7 | Papillomavirus Vaccines - therapeutic use | Humans | Uterine Cervical Neoplasms - prevention & control | Vaccines, DNA - immunology | Uterine Cervical Neoplasms - immunology | Vaccines, DNA - therapeutic use | Uterine Cervical Neoplasms - genetics | Papillomavirus Infections - genetics | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Papillomaviridae - immunology | Vaccination - methods | Papillomavirus Infections - prevention & control | Papillomavirus Infections - immunology | Uterine Cervical Neoplasms - virology | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - immunology | MEDICINE, RESEARCH & EXPERIMENTAL | GAMMA-INDUCIBLE PROTEIN-10 | COLONY-STIMULATING FACTOR | CANCER-IMMUNOTHERAPY | CERVICAL INTRAEPITHELIAL NEOPLASIA | MHC CLASS-I | T-CELL RESPONSES | VIRUS TYPE-1 VP22 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IMMUNE-RESPONSES | GENETICS & HEREDITY | ANTIGEN-PRESENTING CELLS | Medical research | Immunization | Stability | Risk groups | Vaccination | Health risks | Clinical trials | Infections | DNA vaccines | Vaccines | Cervix | Immunity | Anogenital | Human papillomavirus | Etiology | Skin | Manufacturability | Lesions | Cervical cancer | Deoxyribonucleic acid--DNA | Cancer
Journal Article